Evidence map›Paper›PMID 37465764›Full record

ArticleFrontiers in neurology2023

Botulinum toxin type A for genitofemoral neuralgia: A case report.

Yan Tereshko, Belgrado Enrico, Lettieri Christian, Simone Dal Bello, Giovanni Merlino, Gian Luigi Gigli, Mariarosaria Valente

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yan TereshkoClinical Neurology Unit, Udine University Hospital, Udine, Italy.
Belgrado EnricoNeurology Unit, Udine University Hospital, Udine, Italy.
Lettieri ChristianNeurology Unit, Udine University Hospital, Udine, Italy.
Simone Dal BelloClinical Neurology Unit, Udine University Hospital, Udine, Italy.
Giovanni MerlinoClinical Neurology Unit, Udine University Hospital, Udine, Italy.
Gian Luigi GigliDepartment of Medicine (DAME), University of Udine, Udine, Italy.
Mariarosaria ValenteClinical Neurology Unit, Udine University Hospital, Udine, Italy.
University of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genitofemoral neuralgia is an uncommon pain disorder that could be resistant to conventional treatment. A 78-year-old woman with refractory right genitofemoral neuralgia was treated with BoNT/A subcutaneous injections; the treatment was performed three times with significant pain improvement, although temporary, and without adverse events. BoNT/A may be a promising alternative intervention in the setting of genitofemoral neuralgia refractory to oral and/or topical treatment.

Indexed as

botulinum toxin type Agenitofemoral nervegenitofemoral neuralgianeuralgiapain

Identifiers

PMID37465764
PMCPMC10350489
OpenAlexW4382981729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.